| DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk |
NCT01865305: Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes |
|
|
| Completed | 1 | 59 | Europe | insulin degludec/insulin aspart 30, insulin degludec/insulin aspart 40, insulin degludec/insulin aspart 50, insulin degludec, insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 02/07 | 02/07 | | |
NCT01868568: Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 55 | Europe | insulin degludec, insulin degludec/insulin aspart 30, insulin degludec/insulin aspart 40, insulin degludec/insulin aspart 45, insulin degludec/insulin aspart 55, insulin aspart, biphasic insulin aspart 30, placebo | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 08/08 | 08/08 | | |
NCT00993096: Investigation of the Response Relationship of NN5401 in Type 1 Diabetics |
|
|
| Completed | 1 | 33 | Europe | insulin degludec/insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 12/09 | 12/09 | | |
|
NCT00992537: Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics |
|
|
| Completed | 1 | 27 | Europe | insulin degludec, insulin degludec/insulin aspart, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 01/10 | 01/10 | | |
NCT01051102: Effect of NN5401 in Japanese Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 21 | Japan | insulin degludec/insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 04/10 | 04/10 | | |
NCT01138488 / 2009-016779-31: A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 38 | Europe | insulin degludec/insulin aspart | Novo Nordisk A/S, HNEC TEST | Diabetes, Diabetes Mellitus, Type 1 | 11/10 | 11/10 | | |
NCT01173926: Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 27 | Europe | insulin degludec, insulin degludec/insulin aspart, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 11/10 | 11/10 | | |
NCT01174303: A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 28 | Europe | insulin degludec/insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 11/10 | 11/10 | | |
NCT01455142: A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 32 | Europe | insulin degludec/insulin aspart, IDegAsp | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 01/12 | 01/12 | | |
NCT01590836: A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 22 | Europe | insulin degludec, insulin degludec/insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 06/12 | 06/12 | | |
|
NCT01773798: A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 33 | Europe | insulin degludec/insulin aspart 15, insulin degludec/insulin aspart, IDegAsp, insulin degludec, insulin aspart, placebo | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 08/13 | 08/13 | | |
